Bayforest Capital LTD Merck & Co., Inc. Transaction History

Bayforest Capital LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$73.47 - $87.12 $225,846 - $267,806	-3,074 Reduced 99.93%	2 $158,000
Q1 2025 May 08, 2025	BUY	$83.01 - $101.02 $219,727 - $267,399	2,647 Added 617.02%	3,076 $161 Million
Q4 2024 Feb 14, 2025	BUY	$96.31 - $114.76 $41,316 - $49,232	429 New	429 $42.7 Million

3,904

1.9B

30.1M

27.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Bayforest Capital LTD with notifications on news.